Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for the ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance. On June 16, 2017, Alvogen announced it was ...

Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the ...

The Food and Drug Administration on Wednesday approved Baxter International’s clindamycin injection in saline. Clindamycin is a common antibiotic used to treat serious infections when penicillin may ...

Alvogen is arranging with its distributors and customers for the return of the recalled lots of clindamycin. Hospira, a unit of Pfizer, voluntarily recalled four other injectable solutions made at its ...

Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP LOS ANGELES -- Abraxis BioScience, Inc., an integrated, global biopharmaceutical company, today announced that it has received ...

Clindamycin (as phosphate) 150mg/mL; contains benzyl alcohol. Serious: 0.6–1.2g daily. More severe: 1.2–2.7g/day IM or IV. Both: give in 2–4 equally divided doses; max 600mg per IM inj and 4.8g/day IV ...

* Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline * Baxter International - FDA approval and commercial launch of ready-to-use clindamycin ...